Advanced search
Publication Cover
Infectious Diseases Volume 49, 2017 - Issue 5
Submit an article Journal homepage
1,002
Views
21
CrossRef citations to date
0
Altmetric
Brief Report

A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA)

Iffat ShafiqLaboratory for Antimicrobial Pharmacodynamics, Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA; View further author information
,
Zackery P. BulmanLaboratory for Antimicrobial Pharmacodynamics, Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA; View further author information
,
Sarah L. SpitznogleLaboratory for Antimicrobial Pharmacodynamics, Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA; View further author information
,
Justin E. OsorioLaboratory for Antimicrobial Pharmacodynamics, Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA; View further author information
,
Irene S. ReillyLaboratory for Antimicrobial Pharmacodynamics, Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA; View further author information
,
Alan J. LesseInfectious Diseases Department, Veterans Affairs Western New York Healthcare System, Buffalo, NY, USAView further author information
,
Ganapathi I. ParameswaranInfectious Diseases Department, Veterans Affairs Western New York Healthcare System, Buffalo, NY, USAView further author information
,
Kari A. MergenhagenInfectious Diseases Department, Veterans Affairs Western New York Healthcare System, Buffalo, NY, USACorrespondence[email protected]
View further author information
&
Brian T. TsujiLaboratory for Antimicrobial Pharmacodynamics, Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA; Correspondence[email protected]
View further author information
 show all
Pages 410-416 | Received 22 Sep 2016, Accepted 16 Dec 2016, Published online: 24 Jan 2017

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Susana Patrícia Lopes, Paula Jorge, Ana Margarida Sousa & Maria Olívia Pereira. (2021) Discerning the role of polymicrobial biofilms in the ascent, prevalence, and extent of heteroresistance in clinical practice. Critical Reviews in Microbiology 47:2, pages 162-191.
Read now
Daniele Roberto Giacobbe, Silvia Corcione, Antonio Salsano, Filippo Del Puente, Simone Mornese Pinna, Francesco Giuseppe De Rosa, Malgorzata Mikulska, Francesco Santini & Claudio Viscoli. (2019) Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery. Expert Opinion on Pharmacotherapy 20:6, pages 751-772.
Read now
Nicolas Cortes-Penfield, Nora T. Oliver, Andrew Hunter & Maria Rodriguez-Barradas. (2018) Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia. Infectious Diseases 50:8, pages 643-647.
Read now

Articles from other publishers (18)

Frederico Severino Martins, José Eduardo Severino Martins, Patricia Severino, Pieter Annaert & Sherwin K. B. Sy. (2023) Physiologically based pharmacokinetic modelling to inform combination dosing regimens of ceftaroline and daptomycin in special populations. British Journal of Clinical Pharmacology 89:9, pages 2726-2738.
Crossref
Roberta Maria Antonello, Diana Canetti & Niccolò Riccardi. (2023) Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review . Journal of Antimicrobial Chemotherapy 78:1, pages 52-77.
Crossref
Cheng-En Tsai, Chia-Jui Yang, Yu-Chung Chuang, Jann-Tay Wang, Wang-Huei Sheng, Yee-Chun Chen & Shan-Chwen Chang. (2022) Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus. International Journal of Infectious Diseases 122, pages 230-236.
Crossref
Yi-Hu YiJiang-Lin WangWen-Jun YinWei-Hua Xu. (2021) Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: A Systematic Review and Meta-Analysis . Microbial Drug Resistance 27:8, pages 1044-1056.
Crossref
Daniele Roberto Giacobbe, Chiara Russo, Veronica Martini, Silvia Dettori, Federica Briano, Michele Mirabella, Federica Portunato, Chiara Dentone, Sara Mora, Mauro Giacomini, Marco Berruti & Matteo Bassetti. (2021) Use of Ceftaroline in Hospitalized Patients with and without COVID-19: A Descriptive Cross-Sectional Study. Antibiotics 10:7, pages 763.
Crossref
Donald J. AbrahamSebastian A. Testero, Leticia I. Llarrull, Jed F. Fisher & Shahriar Mobashery. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 188 .
Annemieke Bloem, Hannelore I. Bax, Erlangga Yusuf & Nelianne J. Verkaik. (2021) New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis. Journal of Clinical Medicine 10:8, pages 1743.
Crossref
Yujie Gao, Yuan Chen, Yubin Cao, Anchun Mo & Qiang Peng. (2021) Potentials of nanotechnology in treatment of methicillin-resistant Staphylococcus aureus. European Journal of Medicinal Chemistry 213, pages 113056.
Crossref
Masaki Nakamura, Hayato Kawada, Hiroki Uchida, Yusuke Takagi, Shuichi Obata, Ryotaro Eda, Hideaki Hanaki & Hidero Kitasato. (2021) Single nucleotide polymorphism leads to daptomycin resistance causing amino acid substitution—T345I in MprF of clinically isolated MRSA strains. PLOS ONE 16:1, pages e0245732.
Crossref
Omar Ahmad, Timothy N. Crawford & Thein Myint. (2019) Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline. Infectious Diseases and Therapy 9:1, pages 77-87.
Crossref
Bongiorno Dafne, Mongelli Gino, Stefani Stefania & Campanile Floriana. (2019) Genotypic analysis of Italian MRSA strains exhibiting low-level ceftaroline and ceftobiprole resistance. Diagnostic Microbiology and Infectious Disease 95:3, pages 114852.
Crossref
Marcus R. Pereira & Meenakshi M. Rana. (2019) Methicillin‐resistant Staphylococcus aureus in solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice . Clinical Transplantation 33:9.
Crossref
François-Régis Duss, Cristina Garcia de la Mària, Antony Croxatto, Stefano Giulieri, Frédéric Lamoth, Oriol Manuel & José M Miró. (2019) Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report. Journal of Antimicrobial Chemotherapy 74:9, pages 2626-2630.
Crossref
Yang Ye, Zijing Xia, Dan Zhang, Zenghua Sheng, Peng Zhang, Hongxia Zhu, Ningzhi Xu & Shufang Liang. (2019) Multifunctional Pharmaceutical Effects of the Antibiotic Daptomycin. BioMed Research International 2019, pages 1-9.
Crossref
Nicole Lounsbury, Mary Reeber, Georges Mina & Christiane Chbib. (2019) A Mini-Review on Ceftaroline in Bacteremia Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. Antibiotics 8:1, pages 30.
Crossref
Joseph Patrik Hornak, Seher Anjum & David Reynoso. (2019) Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant Staphylococcus aureus bacteremia after monotherapy failure . Therapeutic Advances in Infectious Disease 6, pages 204993611988650.
Crossref
Megumi Yazaki, Takehiko Oami, Kazuya Nakanishi, Ryota Hase & Hiroyuki Watanabe. (2018) A successful salvage therapy with daptomycin and linezolid for right-sided infective endocarditis and septic pulmonary embolism caused by methicillin-resistant Staphylococcus aureus. Journal of Infection and Chemotherapy 24:10, pages 845-848.
Crossref
Ali Hassoun, Peter K. Linden & Bruce Friedman. (2017) Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment. Critical Care 21:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.